Allegria Therapeutics Company Profile, Contacts & Intelligence

Biotechnology ResearchBasel, Basel-stadt, Ch6 employeesFounded 2023
Employees
6
Company source estimate

Allegria Therapeutics Overview

Allegria Therapeutics was founded in Basel, Switzerland by Forty51 Ventures in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that directly and selectively modulate mast cells, Allegria aims to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases. For more information, please visit www.allegriatx.com

Headquarters
Basel, Basel-stadt, Ch
Industry
Biotechnology Research
Founded
2023
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

Compare Similar Companies to Allegria Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Memo Therapeutics AG Biotechnology Research 44 View company
BioVersys AG Biotechnology Research 29 View company
Araris Biotech AG Biotechnology Research 20 View company
AMYRA Biotech AG Biotechnology Research 9 View company
Cellestia Biotech Biotechnology Research 8 View company
Versameb AG Biotechnology 8 View company
Ymmunobio Biotechnology Research 6 View company
CanVirex Biotechnology Research 5 View company
NXI Therapeutics AG Biotechnology Research 5 View company
Adoram Therapeutics Biotechnology Research 4 View company